Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07166952 · ClinicalTrials.gov registry record · NA

Peripheral Nerve Stimulation With the SPRINT® System in Chronic PSIJC Pain

A NA study of Lower Back Pain, sponsored by Medical University of South Carolina.

Recruiting
Registry status
NA
Development phase
10
Enrollment target
2
Study locations

NCT07166952: Recruiting NA study of Lower Back Pain, sponsored by Medical University of South Carolina.

NCT07166952 is a NA study of Lower Back Pain that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 10 participants, below the 25-participant average among 4 other Lower Back Pain trials with a reported enrollment target (60% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07166952, a NA study of Lower Back Pain, is actively recruiting participants, sponsored by Medical University of South Carolina.

RECRUITING
Registry status
NA
Development phase
10 participants
Enrollment target
2
Study locations

Study Summary

Chronic lower back pain is a significant cause of disability, affecting 21-68% of people 60 years of age and older (source). Of these cases, 15-30% are attributed to posterior sacroiliac joint complex (PSIJC) pain (source), making it a target for treatment. Peripheral Nerve Stimulation (PNS) is a procedure that involves the placement of a lead under the skin with local anesthetic and electrically stimulating designated spinal nerves that deliver pain signals to the brain. It has emerged as a promising alternative to drug, injection, and radioablative therapies. Its use has been supported by previous studies of subjects who received permanent neurostimulation and experienced benefits such as decreased sensation of pain and perceived level of disability. SPRINT is a minimally invasive PNS system of interest due to its ability to provide long-term pain relief after temporary administration of PNS. The aim of this study is to understand whether the FDA-cleared SPRINT PNS system is safe and effective for the treatment of chronic PSIJC pain. This prospective clinical study will assess 10 subjects that meet the inclusion and exclusion criteria across 5 separate time points- 1.) Screening; 2.) Procedure within 3 months of screening; 3.) 12-day post-procedure follow-up; 4.) 3-month post-procedure follow-up; 5.) 3-Month post lead removal follow-up. The subjects will be required to complete physical examinations, and VAS and ODI questionnaires at timepoints 3, 4, and 5.

Conditions Studied

Interventions

  • DEVICE SPRINT PNS System

Study Locations (2)

South Carolina

  • Medical University of South Carolina - Charleston
  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2025-10-26
Est. Completion 2027-10-31
Phase NA

What NCT07166952 shows while recruiting

NCT07166952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 25-participant average among 4 other Lower Back Pain trials with a reported enrollment target (60% lower).

The record links to 1 condition, with Lower Back Pain appearing as the primary indexed condition, and to 1 intervention - of which SPRINT PNS System is the first listed.

NCT07166952 reports a single indexed study location in South Carolina.

Frequently Asked Questions

What is clinical trial NCT07166952 about?

NCT07166952 is a clinical study titled "Peripheral Nerve Stimulation With the SPRINT® System in Chronic PSIJC Pain". Chronic lower back pain is a significant cause of disability, affecting 21-68% of people 60 years of age and older (source). Of these cases, 15-30% are attributed to posterior sacroiliac joint complex (PSIJC) pain (source), making it a target for treatment. Peripheral Nerve Stimulation (PNS) is a pr...

What is the current status of trial NCT07166952?

This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2025-10-26. Estimated completion is 2027-10-31.

What conditions does trial NCT07166952 study?

This clinical trial studies the following conditions: Lower Back Pain.

What interventions are being tested in trial NCT07166952?

The interventions under investigation include: SPRINT PNS System (DEVICE).

Who is sponsoring clinical trial NCT07166952?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07166952 being conducted?

This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lower Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07166952, the US trial registry maintained by the National Library of Medicine. NCT07166952 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.